MedPath

Inguinal Hernia Repair and Male Fertility

Not Applicable
Completed
Conditions
Inguinal Hernia Bilateral
Interventions
Procedure: Bilateral hernioplasty
Registration Number
NCT05799742
Lead Sponsor
University of Sao Paulo General Hospital
Brief Summary

General objective: To evaluate the fertility of adult men submitted to bilateral herniorrhaphy with mesh placement by the Lichtenstein and laparoscopic approaches

Detailed Description

Specific objectives: To correlate pre and postoperative data (90 and 180 days) of adult men, according to biochemistry parameters (hemogram and CRP), autoimmune (anti-sperm antibodies), hormonal (FSH, LH and testosterone), perfusion and volume testicular (USG of testicles with Doppler), spermogram, sexual changes, pain and quality of life (standard questionnaires).

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
37
Inclusion Criteria
  • Male
  • Age between 19 and 60 years old
  • Bilateral inguinal hernia
  • Primary and reducible inguinal hernia
Exclusion Criteria
  • Age less than 19 or more than 60 years old
  • ASA >III
  • Genito-urinary infection
  • Immunodeficiency
  • History of testicular trauma2
  • History of surgery or pelvic radiotherapy
  • History of testicular disease
  • Fertility problems or sexual
  • Illness that can be infertile
  • Recurrent hernia
  • Unilateral hernia
  • Femoral or inguine-scrotal hernia
  • Imprisoned hernia
  • Use of Gonadotrophins
  • Use of anabolic steroids

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LichtensteinBilateral hernioplastyConventional approach
LaparoscopyBilateral hernioplastyExperimental approach
Primary Outcome Measures
NameTimeMethod
Sperm Volume180th postoperative day

Sperm Volume (in ml) measured by Semen analysis

Sperm number180th postoperative day

Sperm number in million measured by Semen analysis

Sperm morphology180th postoperative day

Sperm morphology, according to the Kruger classification, evaluated by Semen analysis

Sperm concentration180th postoperative day

Sperm concentration (million sperm/ml) measured by Semen analysis

Testicular vascularization180th postoperative day

Testicular vascularization, normal or not, measured by testicular Doppler ultrasound

Semen analysis180th postoperative day

Volume (ml), Concentration (million/ml), Sperm number (million), Motility (% of progression), Morphology (Kruger classification)

Sperm motility180th postoperative day

Sperm motility in % of progression measured by Semen analysis

Testicular volume180th postoperative day

Testicular volume, in cm3, measured by testicular ultrasound

Secondary Outcome Measures
NameTimeMethod
Luteinizing Hormone (LH) dosage180th postoperative day

Serum LH (IU/L)

Quality-of-life evaluation (SF-36 questionnaire)180th postoperative day

SF36 Domains: Role physical, Physical function, Role emotional, Energy, Emotional health, Social functioning, Bodily pain and General health. Scale ranging from 0 to 100, where zero is the worst state and 100 is the best.

Postoperative pain180th postoperative day

Visual Analog Scale (VAS) score ranging from 0 to 10, with 0 indicating no pain and 10 indicating the worst possible pain

Follicle Stimulating Hormone (FSH) dosage180th postoperative day

Serum FSH (IU/L)

Testosterone Hormone dosage180th postoperative day

Serum Testosterone (ng/dl)

Sex hormone-binding globulin (SHGB) dosage180th postoperative day

Serum SHGB (nmol/L)

Sexual activity180th postoperative day

Satisfied or not with sexual performance, Changes in arousal, Changes in libido and Changes in ejaculation or orgasm (Specific questionnaires)

Trial Locations

Locations (1)

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

🇧🇷

São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath